Publications

Co-author in peer-reviewed journals

  1. Pawlikowska-Gorzelańczyk A, Fichte D, Rozmus J, Roder P, Flakus R, Szuster E, Brawańska K, Biernikiewicz M, Sobieszczańska M, Rusiecka A, Kałka D. Impact of Internet Addiction, Social Media Use and Online Pornography on the Male Sexual Function in Times of the COVID-19 Pandemic. J Clin Med. 2023;12(19):6407
  2. Kalka D, Gebala J, Biernikiewicz M. Commentary on „The impact of the COVID-19 pandemic on erectile function in Chinese CP/CPPS patients”. Asian J Androl. 2023;25(6):753
  3. Smela B, Toumi M, Świerk K, Francois C, Biernikiewicz M, Clay E, Boyer L. Rapid literature review: definition and methodology. J Mark Access Health Policy. 2023;11:1
  4. Bułdyś K, Górnicki T, Kałka D, Szuster E, Biernikiewicz M, Markuszewski L, Sobieszczańska M. What Do We Know about Nociplastic Pain? Healthcare (Basel). 2023 17;11(12):1794
  5. Mandera-Grygierzec A, Kostrzewska P, Szuster E, Pawlikowska-Gorzelańczyk A, Biernikiewicz M, Rusiecka A, Mrozek-Szetela A, Sobieszczańska M, Rożek-Piechura K, Markiewicz M, Kałka D. Low Exercise Tolerance as a Marker of Erectile Dysfunction and Depression among Post-Myocardial Infarction Men. Healthcare (Basel). 2023;11(9):1213
  6. Szuster E, Kostrzewska P, Pawlikowska A, Mandera A, Biernikiewicz M, Sobieszczańska M, Rożek-Piechura K, Jarząbek-Bielecka G, Rusiecka A, Kałka D. Depressive and Sexual Disorders during the First and Second Wave of the COVID-19 Pandemic among Young Polish Women. Int J Environ Res Public Health. 2022;19(3):1887
  7. Szuster E, Kostrzewska P, Pawlikowska A, Mandera A, Biernikiewicz M, Kałka D. Mental and Sexual Health of Polish Women of Reproductive Age During the COVID-19 Pandemic – An Online Survey. Sex Med. 2021;9(4):100367
  8. Skrzypczak T, Błachnio K, Górnicki T, Kmieć J, Ciąder A, Biernikiewicz M, Majchrowska M, Sobieszczańska M, Szymala-Pędzik M, Kałka D. Association between the Desire for Breast Augmentation and Instagram Engagement: A Cross-Sectional Survey among Young Polish Women. Int J Environ Res Public Health. 2021;18(19):10317
  9. Pochopień M, Paterak E, Clay E, Janik J, Aballea S, Biernikiewicz M, Toumi M. An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models. J Mark Access Health Policy. 2021;9(1):2002006
  10. Kałka D, Gebala J, Biernikiewicz M, Mrozek-Szetela A, Rożek-Piechura K, Sobieszczańska M, Szuster E, Majchrowska M, Miętka A, Rusiecka A. Erectile Dysfunction in Men Burdened with the Familial Occurrence of Coronary Artery Disease. J Clin Med. 2021;10(18):4046
  11. Kałka D, Biernikiewicz M, Gebala J, Bielecka-Jarząbek G, Zdrojowy R, Pilecki W. Efficacy of low energy shock-wave therapy generated using an electrohydraulic device in the treatment of ED: a systematic review and meta-analysis of randomized controlled trials. Arch Esp Urol. 2021;74(6):606-617
  12. Biernikiewicz M, Germain N, Toumi M. Second opinions, multiple physician appointments, and overlapping prescriptions in the paediatric population: A systematic literature review. J Eval Clin Pract. 2020;26:1761–176
  13. Kałka D, Biernikiewicz M, Gebala J, Sobieszczańska M, Jakima S, Pilecki W, Rusiecki L. Diagnosis of hypogonadism in patients treated with low energy shock wave therapy for erectile dysfunction: a narrative review. Transl Androl Urol. 2020;9(6):2786-2796
  14. Kałka D, Gebala J, Biernikiewicz M. Re: Electromagnetic Low-intensity Extracorporeal Shock Wave Therapy in Patients with Erectile Dysfunction: A Sham-controlled, Double-blind, Randomized Prospective Study. Eur Urol. 2020;78(1):110-111
  15. Han R, Liang S, Biernikiewicz M, Wang Y, Toumi, M. What Makes the UK Recovery Trial More Pragmatic than the European Discovery Trial? Preprints 2020, 2020060229
  16. Toumi M, Biernikiewicz M, Liang S, Wang Y, Qiu T, Han R. A critical analysis and review of Lancet COVID-19 hydroxychloroquine study. J Mark Access Health Policy. 2020;8(1):1809236
  17. Biernikiewicz M, Taieb V, Toumi M. Characteristics of doctor-shoppers: a systematic literature review. J Mark Access Health Policy. 2019;7(1):1595953

Posters / Abstracts

Co-author in ISPOR posters/abstract

  1. Smela B, Toumi M, Świerk K, Francois C, Biernikiewicz M, Clay E, Boyer L. Definition and Methodology of Rapid Literature Reviews. A51,2023-11, ISPOR Europe 2023, Copenhagen, Denmark
  2. Kałka D, Biernikiewicz M, Kostrzewska P, Pawlikowska A, Mandera A, Gebala J, Szuster E. Mental and Sexual Health of Men in Times of COVID-19 Lockdown. PIH3,2020-11, ISPOR Europe 2020, Milan, Italy
  3. Szuster E, Kostrzewska P, Pawlikowska A, Mandera A, Gebala J, Biernikiewicz M, Kałka D. IMPACT of the COVID-19 Outbreak on Mental and Sexual Health in Women. PMH4,2020-11, ISPOR Europe 2020, Milan, Italy
  4. Biernikiewicz M, Taieb V, Toumi M. Characteristics of doctor-shoppers- a systematic literature review. PHP2,2018-11, ISPOR Europe 2018, Barcelona, Spain
  5. Jaafer N, Biernikiewicz M, Toumi M. Physician-related factors in doctor-shopping- a systematic literature review. PHP334,2018-11, ISPOR Europe 2018, Barcelona, Spain
  6. Biernikiewicz M, Germain N, Toumi M. Demand for second opinions in the paediatric population- a systematic review of the literature. PHP158,2018-11, ISPOR Europe 2018, Barcelona, Spain

Support for Writing

Support for medical writing

  1. Oshima Y, Fujimoto T, Nomoto M, Fukui J, Ikoma A. Hyperhidrosis: A targeted literature review of the disease burden. J Dermatol. 2023;50(10):1227-1236
  2. Folkerts K et al. Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease. J Nephrol. 2023;36(4):1135-1167
  3. Wu O et al. Effectiveness and safety of nonvitamin k oral anticoagulants rivaroxaban and apixaban in patients with venous thromboembolism: a meta-analysis of real-world studies. Cardiovasc Ther. 2022;2022:2756682
  4. Igarashi A et al. iStent inject® and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysis. Int J Ophthalmol. 2022;15(6):954-961
  5. Arbo A et al. Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay. Hum Vaccin Immunother. 2022;18(5):2069974
  6. Igarashi A et al. Burden of illness associated with pneumococcal infections in Japan – a targeted literature review. J Mark Access Health Policy. 2021;10(1):2010956
  7. Vashi P et al. Indirect treatment comparison of damoctocog alfa pegol versus turoctocog alfa pegol as prophylactic treatment in patients with hemophilia A. J Blood Med. 2021;12:935-943
  8. Kemp R et al. Relationship between FEV1 decline and mortality in patients with bronchiolitis obliterans syndrome—a systematic literature review. Resp Med, 2021; 188:106608
  9. Dronova M et al. Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan. Curr Med Res Opin. 2021;37(7):1135-1148.
  10. Bebrysz M et al. How pet owners choose antiparasitic treatments for their dogs: A discrete choice experiment. Preventive Veterinary Medicine 2021; 196:105493
  11. Taieb V et al. Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients – a Bayesian network meta-analysis. Curr Med Res Opin. 2020:1-20
  12. Ohji M et al. Efficacy and Treatment Burden of Intravitreal Aflibercept Versus Intravitreal Ranibizumab Treat-and-Extend Regimens at 2 Years: Network Meta-Analysis Incorporating Individual Patient Data Meta-Regression and Matching-Adjusted Indirect Comparison. Adv Ther. 2020;37(5):2184-2198
  13. Han R et al. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results. Appl Health Econ Health Policy. 2021;19(1):29-44
  14. Bauersachs R et al. Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials. Cardiovasc Ther. 2020;2020:3057168
  15. Aballéa S et al. Health economic evaluation of gene replacement therapies: methodological issues and recommendations. J Mark Access Health Policy. 2020;8(1):1822666
  16. Igarashi A et al. Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis. J Dermatol. 2019;46(8):652-661
  17. Hori M et al. Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting. J Med Econ. 2020;23(3):252-261
  18. Zhou J et al. Systematic review of pharmacoeconomic models for schizophrenia. J Mark Access Health Policy. 2018;6(1):1508272